Brief: Allakos Inc Says On August 25 Board Increased Authorized Number Of Directors On Board From Eight To Nine Members
Allakos Inc reports results for the quarter ended in June - Earnings Summary
Stifel resumes coverage of Lonza with 'hold' citing short-term challenges
U.S. RESEARCH ROUNDUP-Allakos, Virtu Financial, Walt Disney
Allakos Inc reports results for the quarter ended in March - Earnings Summary
Brief: Allakos Reports First Quarter Results
Allakos Inc expected to post a loss of 49 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Office Properties Income Trust, Radius Global Infrastructure
Brief: Allakos Inc - QTRLY Loss Per Share $0.50
Allakos Inc reports results for the quarter ended in December - Earnings Summary
Allakos Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Allakos Plans To Initiate First-In-Human Study Of Ak006 During 1H 2023
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
Brief: Allakos Reports Third Quarter 2022 Financial Results
Allakos Inc reports results for the quarter ended in September - Earnings Summary
Allakos Inc expected to post a loss of 78 cents a share - Earnings Preview
Brief: New Enterprise Associates 16 LP Reports 7.3% Stake In Allakos Inc
U.S. STOCKS ON THE MOVE-Rumble Inc, Virios Therapeutics, KnowBe4